Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report

Melanoma is a frequent neoplasm in young adult males in reproductive age, 10% of them degenerating into regional and/or distant metastases (MM). The use of BRAF inhibitors (BRAFi) vemurafenib and dabrafenib is effective in MM patients harboring BRAF V600E/K/D mutations. Despite the increased life ex...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Ghezzi, Marco, Garolla, Andrea, Magagna, Sabina, Šabovich, Iva, Berretta, Massimiliano, Foresta, Carlo, De Toni, Luca
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066495/
https://ncbi.nlm.nih.gov/pubmed/32211316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00232
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki